Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients.
Kalin
Mats
M
Kristinsson
Sigurdur Yngvi
SY
Cherif
Honar
H
Lebbad
Marianne
M
Björkholm
Magnus
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced / Q000209:etiology / Q000401:mortality*; D012189:Retrospective Studies; D014747:Vinblastine / Q000009:adverse effects; D055815:Young Adult
D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin